Literature DB >> 22018502

Iliac-femoral venous stenting for lower extremity venous stasis symptoms.

Saadi Alhalbouni1, Anil Hingorani, Alexander Shiferson, Kapil Gopal, Daniel Jung, Danny Novak, Natalie Marks, Enrico Ascher.   

Abstract

BACKGROUND: Venous outflow obstruction may play a role in patients with chronic venous stasis symptoms who fail to improve despite conventional modalities of treatment that focus on the reflux component of the disease with little attention to the possibility of an obstructive component. The introduction of minimally invasive venous stenting using venography and intravenous ultrasonography (IVUS) provides the ability to treat the "obstructive" component of the disease.
METHODS: We undertook a retrospective review of 56 limbs in 53 patients with chronic venous stasis symptoms. Initial transcutaneous Doppler ultrasonographic evaluation of the inferior vena cava, iliac, femoral, greater saphenous, and perforator veins was performed looking for any evidence of deep venous thrombosis, superficial venous thrombosis, perforator veins, and reflux (location and degree). Afterword, the patients were managed in the conventional fashion (leg elevation, compression, and great saphenous vein (GSV) and perforator ablation, if present) for a period of 3 months. If ulcer healing was not noted, iliac-femoral venography and IVUS were undertaken. A significant stenosis was defined as a 50% reduction in vein cross-sectional area as measured by IVUS.(1,2,3) Stenotic lesions were managed with stenting followed by balloon angioplasty. Patients were followed up for ulcer healing or improvement of stasis symptoms.
RESULTS: Of the 56 limbs, 10 (17.8%) had postthrombotic changes, 7 (12.5%) had incompetent perforators, and 27 (48.2%) had an incompetent superficial venous system. In the stented group (n = 29), 3 limbs had perforator ablation alone, 13 limbs had GSV ablation alone, and 1 limb had both perforator and GSV ablation. In the unstented group (n = 27), 10 limbs had GSV ablation alone, and 3 limbs had both perforator and GSV ablation. The overall incidence of deep reflux was 51.8%; 17 of 29 limbs (58.6%) in the stented group had evidence of deep reflux, and 12 of 27 limbs (44.4%) in the unstented group had deep reflux. All venograms except one (98.2%) were performed under local anesthesia with sedation. The procedure was performed in an ambulatory setting in 69.6% (39 of 56) of the limbs. CEAP clinical severity class distribution was as follows: C2, 4%; C3, 16%; C4, 18%; C5, 5%; C6, 57%. Over half of the limbs (29 of 56) were found to have stenotic lesions and required stenting. Eight patients (11 limbs) did not return for ulcer healing assessment. The majority (19 of 29) of limbs in the stented group had a CEAP of 6. Among the patients with CEAP 6 who returned for follow-up (n = 26), 7 had no evidence of stenosis and required no stenting. Only one of those (14.3%) healed his ulcers after 3 months (average follow-up of 4.8 months). The remainder 19 limbs were found to have stenotic lesions and underwent stenting. The ulcers healed in 11 of those (58%) over a period of 1 week to 8 months (average of 5 months), with average follow-up of 3.6 months (p = 0.08). The cumulative primary and secondary patency rates were 93.1% (27 of 29) and 100% (29 of 29), respectively. Two stent thromboses occurred within 4 weeks of the initial procedure. Both occurred in patients with postthrombotic obstruction. One patient developed a superficial femoral artery pseudoaneurysm.
CONCLUSION: Over half of our patients with open ulcers had stenotic lesions. The ulcers healed in 58% of the stented limbs. That indicates that outflow obstruction may play a significant role in patients with chronic venous stasis symptoms, especially those with open ulcers who failed to respond to other treatment modalities. The procedure itself is relatively safe and simple and can be performed on an ambulatory basis.
Copyright © 2012 Annals of Vascular Surgery Inc. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 22018502     DOI: 10.1016/j.avsg.2011.05.033

Source DB:  PubMed          Journal:  Ann Vasc Surg        ISSN: 0890-5096            Impact factor:   1.466


  7 in total

Review 1.  Central Venous Pathologies: Treatments and Economic Impact.

Authors:  Kenneth Ouriel
Journal:  Methodist Debakey Cardiovasc J       Date:  2018 Jul-Sep

2.  Recanalization and flow regulate venous thrombus resolution and matrix metalloproteinase expression in vivo.

Authors:  Christine Chabasse; Suzanne A Siefert; Mohammed Chaudry; Mark H Hoofnagle; Brajesh K Lal; Rajabrata Sarkar
Journal:  J Vasc Surg Venous Lymphat Disord       Date:  2014-05-10

3.  Venoplasty and Venous Stenting in Patients with Chronic Venous Insufficiency in the Lower Extremities.

Authors:  Majid Moeini; Mohammad Reza Zafarghandi; Morteza Shahbandari; Azadeh Sayarifard; Morteza Taghavi; Javad Salimi; Pezhman Farshidmehr; Mohammad Hasani; Mohammad Reza Tobaei
Journal:  J Tehran Heart Cent       Date:  2016-10-03

Review 4.  An estimate of the economic burden of venous leg ulcers associated with deep venous disease.

Authors:  Raghu Kolluri; Marzia Lugli; Laurencia Villalba; Ramon Varcoe; Oscar Maleti; Fernando Gallardo; Stephen Black; Fannie Forgues; Michael Lichtenberg; Jordan Hinahara; Saranya Ramakrishnan; Joshua A Beckman
Journal:  Vasc Med       Date:  2021-08-16       Impact factor: 3.239

5.  Stent extension into a single inflow vessel is a valuable option after endophlebectomy.

Authors:  Timme Maj van Vuuren; Ralph Lm Kurstjens; Mark Af de Wolf; Jorinde Hh van Laanen; Cees Ha Wittens; Rick de Graaf
Journal:  Phlebology       Date:  2017-11-07       Impact factor: 1.740

6.  Iliac venous stenting for outflow obstruction does not significantly change the quality of life of patients with severe chronic venous insufficiency.

Authors:  Alexander Shiferson; Edouard Aboian; Michael Shih; Qinghua Pu; Theresa Jacob; Robert Y Rhee
Journal:  JRSM Cardiovasc Dis       Date:  2019-11-26

7.  Pivotal Study Evaluating the Safety and Effectiveness of the Abre Venous Self-Expanding Stent System in Patients With Symptomatic Iliofemoral Venous Outflow Obstruction.

Authors:  Erin Murphy; Kathleen Gibson; Marc Sapoval; David J Dexter; Raghu Kolluri; Mahmood Razavi; Stephen Black
Journal:  Circ Cardiovasc Interv       Date:  2022-02-02       Impact factor: 6.546

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.